Author:
Morrison Isaac J.,Zhang Jianan,Lin Jingwen,Murray JeAnn E.,Porter Roy,Langat Moses K.,Sadgrove Nicholas J.,Barker James,Zhang Guodong,Delgoda Rupika
Abstract
AbstractColorectal cancer (CRC) represents the third leading cause of death among cancer patients below the age of 50, necessitating improved treatment and prevention initiatives. A crude methanol extract from the wood pulp of Artocarpus heterophyllus was found to be the most bioactive among multiple others, and an enriched extract containing 84% (w/v) artocarpin (determined by HPLC–MS–DAD) was prepared. The enriched extract irreversibly inhibited the activity of human cytochrome P450 CYP2C9, an enzyme previously shown to be overexpressed in CRC models. In vitro evaluations on heterologously expressed microsomes, revealed irreversible inhibitory kinetics with an IC50 value of 0.46 µg/mL. Time- and concentration-dependent cytotoxicity was observed on human cancerous HCT116 cells with an IC50 value of 4.23 mg/L in 72 h. We then employed the azoxymethane (AOM)/dextran sodium sulfate (DSS) colitis-induced model in C57BL/6 mice, which revealed that the enriched extract suppressed tumor multiplicity, reduced the protein expression of proliferating cell nuclear antigen, and attenuated the gene expression of proinflammatory cytokines (Il-6 and Ifn-γ) and protumorigenic markers (Pcna, Axin2, Vegf, and Myc). The extract significantly (p = 0.03) attenuated (threefold) the gene expression of murine Cyp2c37, an enzyme homologous to the human CYP2C9 enzyme. These promising chemopreventive, cytotoxic, anticancer and anti-inflammatory responses, combined with an absence of toxicity, validate further evaluation of A. heterophyllus extract as a therapeutic agent.
Funder
Graduate Studies and Research Grant
University of the West Indies Development Fund
HATCH
Caribbean Public Health Agency and National Cancer Institute
National Commission for Science and Technology, Jamaica
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA Cancer J. Clin. 70, 7–30. https://doi.org/10.3322/caac.21590 (2020).
2. Gibson, T., Hanchard, B., Waugh, N. & McNaughton, D. Age-specific incidence of cancer in Kingston and St Andrew, Jamaica, 2003–2007. West Indian Med. J. 59, 456–464 (2010).
3. Wu, A., Paganini-Hill, A., Ross, R. & Henderson, B. Alcohol, physical activity and other risk factors for colorectal cancer: A prospective study. Br. J. Cancer 55, 687–694. https://doi.org/10.1038/bjc.1987.140 (1987).
4. Bhandari, A., Woodhouse, M. & Gupta, S. Colorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50 years in the USA: A SEER-based analysis with comparison to other young-onset cancers. J. Investig. Med. 65, 311–315. https://doi.org/10.1136/jim-2016-000229 (2017).
5. Plummer, J. M. et al. Colorectal cancer survival in Jamaica. Ann. Med. Surg. 6, 26–29 (2016).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献